Best Oncology Presentation

This award is presented for the best oncology presentation at the USANZ ASM. It aims to recognise the outstanding oncology research that is being conducted in Australia and New Zealand.
 

Background

Introduced at the 2023 ASM, this award is part of an arrangement with the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group for reciprocal entitlement for speakers at respective ASMs.
 

Eligibility

The following eligibility criteria must be met for this award:

• The first and/or senior author must be a USANZ Full Member or Fellow.
• The presentation must have been accepted as a submitted abstract

Keith Kirkland and Villis Marshall presentations will not be considered for this award
 

Judging Process

The Leader of the Genitourinary Specialty Advisory Group (GUSAG Leader) will lead the judging for this award, working with the ASM Scientific Committee Chair to review all abstracts and develop a shortlist of oncology presentations to be judged, then appointing judges with expertise in Genitourinary Oncology. The GUSAG Leader will determine if formal scoring sheets will be used or whether a winner will be picked by consensus following discussion.

The judges will consider the following factors:

• Originality of the research
• The degree to which the research is likely to impact upon or improve patient care or outcomes.
• Higher level evidence as defined by the Oxford Centre for Evidence-Based Medicine (Oxford EBM) will be ranked accordingly
• Trials must be Human Resource Ethics Committee (HREC) approved.
   

Prize and Presentation

This award will be presented at the USANZ ASM Gala Dinner.

The prize consists of an invitation to deliver the USANZ ASM Best Oncology Presentation at the ANZUP ASM. ANZUP will fund the recipient’s airfares, two nights accommodation and registration to attend the meeting. Under the reciprocal arrangement, USANZ will fund the same entitlements for ANZUP speaker to attend the USANZ meeting.